Dr. Smallwood has more than 30 years experience as a practicing hospital pharmacist
with 15 years as a clinical pharmacy specialist with a liver transplant team. He comes
to PCOM School of Pharmacy from the School of Medicine at Emory University. He has
published over 40 peer-reviewed articles, has made numerous national and international
scientific presentations, is on the editorial board of Annals of Pharmacotherapy,
and is a grant reviewer for the country of Qatar.
Dr. Smallwood has been an investigator or co-investigator of more than 40 human clinical trials. His research interest includes immunology, transplant, and diabetes with his most recent work being with the Immune Tolerance Network (ITN) using immunosuppressants in treating Type 1 diabetes which is funded by the National Institute of Allergy and Infectious Disease (NIAID) of the National Institute of Health (NIH).
PharmD, University of Georgia College of Pharmacy, 2001
BS (Phr), University of Georgia College of Pharmacy,1979
Dr. Smallwood currently coordinates several courses within the School of Pharmacy. He teaches the Clinical Pharmacy course for P3 students as well as coordinates the Sterile Laboratory associated with this course. He also teaches in several of the integrated therapeutics courses for the P3 students. For the P2 students in the School of Pharmacy he coordinates Pharmacokinetics.
Elected as a Fellow of the American College of Clinical Pharmacy (ACCP). October 21, 2012 at the 2012 Annual Meeting in Hollywood, Florida.
President Choice Award, Emergence of drug resistance cytomegalovirus following liver transplantation. American Association for the Study of Liver Disease (AASLD) annual meeting. November 12-15, 2005; San Francisco, CA
Recipient of an Award of Excellence in Pharmacy. Relationship between immunosuppression and osteoporosis in an outpatient liver transplant clinic. 3rd International Congress on Immunosuppression. December, 2004 - Manchester Grand Hyatt San Diego, San Diego, CA
President Choice Award, Increased survival in pediatric acute hepatic failure following liver transplantation with early surgical intervention utilizing living donor, partial grafts, and ABO incompatible grafts. American Association for the Study of Liver Disease (AASLD) annual meeting. November 2005; San Francisco, CA
Volunteer and Leadership:
Community Advisory Panel (CAP) Member for the PBRN (Practice Based Research Network) of the American College of Clinical Pharmacist (ACCP)
Member of the Institutional Review Board (IRB), Biomedical Committee Emory University, Atlanta, Ga
Frontiers – PRN Representative, American College of Clinical Pharmacist (ACCP)
Planning committee for the Immune Tolerance Network (ITN) sponsored by NIAID entitled: ITN045AI: Multicenter, randomized trial entitled: Inducing Remission in New Onset T1DM with Alefacept (Amevive®).
International Committee member to develop a non-adherence consensus statement in solid organ transplantation for the American Society of Transplantation(AST), American Society of Transplant Surgeons(ASTS), and the International Pediatric Transplant Society(IPTS)
Enhancing Wellness: Lifelong Success for the Transplant Patient website. Health Maintenance Committee, American Society of Transplantation (AST). November 2005
Planning committee member for the Baylor HCV project following liver transplantation sponsored by Baylor Medical Center and Roche